Impact of the COVID-19 pandemic on multidrug-resistant hospital-acquired bacterial infections.
作者信息
Bongiovanni M, Barilaro G, Zanini U, Giuliani G
机构信息
Department of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Department of Autoimmune Diseases, Hospital Clinic, Universitat de Barcelona, Catalonia, Spain.
出版信息
J Hosp Infect. 2022 May;123:191-192. doi: 10.1016/j.jhin.2022.02.015. Epub 2022 Mar 1.
Abstract
摘要
相似文献
1
Impact of the COVID-19 pandemic on multidrug-resistant hospital-acquired bacterial infections.新冠疫情对多重耐药医院获得性细菌感染的影响。
J Hosp Infect. 2022 May;123:191-192. doi: 10.1016/j.jhin.2022.02.015. Epub 2022 Mar 1.
2
Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study.在 COVID-19 大流行期间减少耐多药（MDR）细菌感染：一项回顾性研究。
Int J Environ Res Public Health. 2021 Jan 23;18(3):1003. doi: 10.3390/ijerph18031003.
3
A multidrug-resistant outbreak in a Peruvian hospital: Another threat from the COVID-19 pandemic.秘鲁一家医院发生多重耐药菌暴发：新冠疫情带来的又一威胁。
Infect Control Hosp Epidemiol. 2022 Feb;43(2):267-268. doi: 10.1017/ice.2020.1401. Epub 2021 Jan 5.
4
Mortality attributable to hospital acquired infections with multidrug-resistant bacteria in a large group of German hospitals.在德国的一大批医院中，归因于医院获得性多重耐药菌感染的死亡率。
J Infect Public Health. 2020 Feb;13(2):204-210. doi: 10.1016/j.jiph.2019.07.025. Epub 2019 Aug 13.
5
Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.新型冠状病毒肺炎大流行对巴西一家急症医院多重耐药细菌感染发生率的影响。
Am J Infect Control. 2022 Feb;50(2):238-239. doi: 10.1016/j.ajic.2021.10.014.
6
An emerging multidrug-resistant bacteria.一种新出现的多重耐药细菌。
CMAJ. 2017 Sep 5;189(35):E1115. doi: 10.1503/cmaj.170110.
7
Lowering methodological standards for studies of multidrug-resistant bacteria is counterproductive.降低耐多药细菌研究的方法学标准会适得其反。
Clin Microbiol Infect. 2016 Jun;22(6):497-8. doi: 10.1016/j.cmi.2016.03.024. Epub 2016 Apr 2.
8
The impact of the COVID-19 pandemic on healthcare acquired infections with multidrug resistant organisms.COVID-19 大流行对医疗保健获得性耐多药生物体感染的影响。
Am J Infect Control. 2021 May;49(5):653-654. doi: 10.1016/j.ajic.2020.09.013. Epub 2020 Oct 2.
9
[Multidrug-resistant bacteria require new treatment options].多重耐药细菌需要新的治疗选择。
Med Monatsschr Pharm. 2015 Dec;38(12):517-21.
10
COVID-19: Impact on prescribing and antimicrobial resistance.新型冠状病毒肺炎：对处方和抗菌药物耐药性的影响。
Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):63-68. doi: 10.37201/req/s01.19.2021. Epub 2021 Sep 30.
引用本文的文献
1
Development of Naphthalene-Derivative Bis-QACs as Potent Antimicrobials: Unraveling Structure-Activity Relationship and Microbiological Properties.萘衍生物双季铵盐作为强效抗菌剂的开发：揭示构效关系和微生物学特性
Molecules. 2024 Nov 22;29(23):5526. doi: 10.3390/molecules29235526.
2
Impact of the COVID-19 pandemic on prevalence of highly resistant microorganisms in hospitalised patients in the Netherlands, March 2020 to August 2022.2020 年 3 月至 2022 年 8 月期间，荷兰住院患者中高度耐药微生物流行情况受 COVID-19 大流行的影响。
Euro Surveill. 2023 Dec;28(50). doi: 10.2807/1560-7917.ES.2023.28.50.2300152.
3
Coronavirus disease 2019 (COVID-19) impact on central-line-associated bloodstream infections (CLABSI): a systematic review.2019年冠状病毒病（COVID-19）对中心静脉导管相关血流感染（CLABSI）的影响：一项系统评价
Infect Prev Pract. 2023 Oct 13;5(4):100313. doi: 10.1016/j.infpip.2023.100313. eCollection 2023 Dec.
4
Antimicrobial resistance pattern in clinical and isolates obtained from a secondary-care hospital prior to and during the COVID-19 pandemic in Kuwait.科威特在新冠疫情之前及期间，从一家二级护理医院获取的临床及分离株中的抗菌药物耐药模式。
Germs. 2022 Sep 30;12(3):372-383. doi: 10.18683/germs.2022.1341. eCollection 2022 Sep.
5
Changing Genotypic Distribution, Antimicrobial Susceptibilities, and Risk Factors of Urinary Tract Infection Caused by Carbapenemase-Producing .产碳青霉烯酶肠杆菌科细菌所致尿路感染的基因型分布、药敏结果及危险因素变化
Ann Lab Med. 2024 Jan 1;44(1):38-46. doi: 10.3343/alm.2024.44.1.38. Epub 2023 Sep 4.
6
Epidemiology of multidrug-resistant organisms before and during COVID-19 in Hong Kong.香港COVID-19疫情之前及期间多重耐药菌的流行病学情况
Infect Prev Pract. 2023 Jun;5(2):100286. doi: 10.1016/j.infpip.2023.100286. Epub 2023 May 8.
7
Bacteremia in a Tertiary Hospital and Factors Associated with Mortality.三级医院的菌血症及其与死亡率相关的因素。
Antibiotics (Basel). 2023 Mar 29;12(4):670. doi: 10.3390/antibiotics12040670.
8
Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic.在 COVID-19 大流行期间，革兰氏阴性 ESKAPE 细菌血流感染患者。
PeerJ. 2023 Mar 29;11:e15007. doi: 10.7717/peerj.15007. eCollection 2023.
9
Bloodstream Infections in SARS-CoV-2 Infected Patients: A Systematic Review.2019冠状病毒病感染患者的血流感染：一项系统评价
J Clin Med. 2023 Mar 14;12(6):2252. doi: 10.3390/jcm12062252.
10
A Perfect Storm: COVID-19 and Antimicrobial Resistance.一场完美风暴：新冠疫情与抗菌药物耐药性
EMJ, Microbiol Infect Dis (Eur Ed). 2022 Sep;2022. doi: 10.33590/emjmicrobiolinfectdis/22-00082. Epub 2022 Sep 5.
本文引用的文献
1
Trend analysis of carbapenem-resistant Gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era: an extra challenge for healthcare institutions.后 COVID-19 时代耐碳青霉烯类革兰氏阴性菌流行趋势及抗菌药物使用分析：医疗机构面临的额外挑战。
J Hosp Infect. 2022 Feb;120:43-47. doi: 10.1016/j.jhin.2021.11.011. Epub 2021 Nov 19.
2
Impact of the COVID-19 pandemic on the surveillance of antimicrobial resistance.COVID-19 大流行对抗菌药物耐药性监测的影响。
J Hosp Infect. 2021 Nov;117:147-156. doi: 10.1016/j.jhin.2021.09.011. Epub 2021 Sep 22.
3
Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study.在 COVID-19 大流行期间减少耐多药（MDR）细菌感染：一项回顾性研究。
Int J Environ Res Public Health. 2021 Jan 23;18(3):1003. doi: 10.3390/ijerph18031003.
4
Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?冠状病毒病（COVID-19）会对抗菌素耐药性产生影响吗？
Euro Surveill. 2020 Nov;25(45). doi: 10.2807/1560-7917.ES.2020.25.45.2001886.
5
Unintended consequences of infection prevention and control measures during COVID-19 pandemic.新冠大流行期间感染预防和控制措施的意外后果。
Am J Infect Control. 2021 Apr;49(4):469-477. doi: 10.1016/j.ajic.2020.10.019. Epub 2020 Nov 4.
6
Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work?抗菌药物管理计划、2019冠状病毒病与感染控制：耐碳青霉烯类肺炎克雷伯菌在新冠肺炎重症监护病房患者中的定植传播。哪些措施无效？
J Clin Med. 2020 Aug 25;9(9):2744. doi: 10.3390/jcm9092744.
7
Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic.ICU 中的抗菌药物耐药性：COVID-19 大流行背景下的最新进展。
Curr Opin Crit Care. 2020 Oct;26(5):433-441. doi: 10.1097/MCC.0000000000000755.
8
Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact.新冠疫情时代的多重耐药感染：一个考量潜在影响的框架
J Hosp Infect. 2020 Sep;106(1):198-199. doi: 10.1016/j.jhin.2020.05.020. Epub 2020 May 17.
Zotero 插件